1 IDENTIFICATION OF THE SUBSTANCE/PREPARATION AND OF THE COMPANY/UNDERTAKING
Scott BaderWollastonWellingboroughNorthamptonshire. NN29 7RLTel: +44(0)1933 663100Emergency (24 hours) +44(0)1933 663399Fax: +44(0)1933 663693E-mail: email@example.com
Irritating to eyes, respiratory system and skin. May cause sensitisation by skin contact. Harmful by inhalation and in contact with skin.
The Full Text for all R-Phrases is Displayed in Section 16
COMPOSITION COMMENTSUrethane Acrylate Resin in reactive solvent
GENERAL INFORMATIONMove the exposed person to fresh air at once. Get medical attention if any discomfort continues.
INHALATIONMove the exposed person to fresh air at once. For breathing difficulties oxygen may be necessary. If breathing stops, provide artificial respiration. Keep the affected person warm and at rest. Get prompt medical attention.
INGESTIONDO NOT INDUCE VOMITING! NEVER MAKE AN UNCONSCIOUS PERSON VOMIT OR DRINK FLUIDS! Remove victim immediately from source of exposure. Immediately rinse mouth and provide fresh air. Get medical attention immediately! NOTE! Keep affected person away from heat, sparks and flames!SKIN CONTACTRemove affected person from source of contamination. Wash the skin immediately with soap and water. Get medical attention if irritation persists after washing.
EYE CONTACTRemove victim immediately from source of exposure. Make sure to remove any contact lenses from the eyes before rinsing. Promptly wash eyes with plenty of water while lifting the eye lids. Continue to rinse for at least 15 minutes. Contact physician if irritation persists.
EXTINGUISHING MEDIAFire can be extinguished using: Foam. Dry chemicals, sand, dolomite etc.
SPECIAL FIRE FIGHTING PROCEDURESMove container from fire area if it can be done without risk. Containers close to fire should be removed or cooled with water. Cool containers exposed to flames with water until well after the fire is out. Keep run-off water out of sewers and water sources. Dike for water control.
UNUSUAL FIRE & EXPLOSION HAZARDSHIGHLY FLAMMABLE! Vapours are heavier than air and may spread near ground to sources of ignition.
SPILL CLEAN UP METHODSExtinguish all ignition sources. Avoid sparks, flames, heat and smoking. Ventilate. Stop leak if possible without risk. Provide ventilation and confine spill. Do not allow runoff to sewer. Absorb in vermiculite, dry sand or earth and place into containers.
USAGE PRECAUTIONSStatic electricity and formation of sparks must be prevented. Keep away from heat, sparks and open flame. Use explosion proof electric equipment. Avoid spilling, skin and eye contact. Ventilate well, avoid breathing vapours. Use approved respirator if air contamination is above accepted level.
STORAGE PRECAUTIONSStore in tightly closed original container in a dry, cool and well-ventilated place. Keep in original container.
STORAGE CLASSFlammable liquid storage.
INGREDIENT COMMENTSWEL = Workplace Exposure LimitsPROTECTIVE EQUIPMENT
ENGINEERING MEASURESExplosion-proof general and local exhaust ventilation.
RESPIRATORY EQUIPMENTNo specific recommendation made, but respiratory protection must be used if the general level exceeds the recommended occupational exposure limit.
HAND PROTECTIONUse protective gloves.
EYE PROTECTIONWear approved safety goggles.
OTHER PROTECTIONWear appropriate clothing to prevent any possibility of liquid contact and repeated or prolonged vapour contact.
HYGIENE MEASURESDO NOT SMOKE IN WORK AREA! Wash at the end of each work shift and before eating, smoking and using the toilet. Promptly remove any clothing that becomes contaminated. When using do not eat, drink or smoke.
STABILITYStable under normal temperature conditions.
CONDITIONS TO AVOIDAvoid heat. Avoid contact with oxidisers or reducing agents.
HAZARDOUS DECOMPOSITION PRODUCTSFire creates: Vapours/gases/fumes of: Carbon monoxide (CO). Carbon dioxide (CO2).
INHALATIONHarmful by inhalation. High concentrations of vapours may irritate respiratory system and lead to headache, fatigue, nausea and vomiting. Vapour from this chemical can be hazardous when inhaled. Vapours may cause headache, fatigue, dizziness and nausea.
INGESTIONMay cause stomach pain or vomiting.
SKIN CONTACTActs as a defatting agent on skin. May cause cracking of skin, and eczema.
EYE CONTACTIrritation of eyes and mucous membranes.
MEDICAL SYMPTOMSIrritation of eyes and mucous membranes.
ECOTOXICITYThe product is not expected to be hazardous to the environment.
DISPOSAL METHODSDispose of waste and residues in accordance with local authority requirements.
Irritating to eyes, respiratory system and skin.
May cause sensitisation by skin contact.
Harmful by inhalation and in contact with skin.
In case of contact with eyes, rinse immediately with plenty of water and seek medical advice.
Wear suitable protective clothing and gloves.
This material and its container must be disposed of as hazardous waste.
EU DIRECTIVESRegulation (EC) No 1907/2006 of the European Parliament and of the Council of 18 December 2006 concerning the Registration, Evaluation, Authorisation and Restriction of Chemicals (REACH), establishing a European Chemicals Agency, amending Directive 1999/45/EC and repealing Council Regulation (EEC) No 793/93 and Commission Regulation (EC) No 1488/94 as well as Council Directive 76/769/EEC and Commission Directives 91/155/EEC, 93/67/EEC, 93/105/EC and 2000/21/EC, including amendments.
Harmful in contact with skin and if swallowed.
Irritating to respiratory system and skin.
May cause sensitisation by skin contact.
Risk of explosion by shock, friction, fire or other sources of ignition.
Toxic to aquatic organisms, may cause long-term adverse effects in the aquatic environment.
Vorgang Nr. 92/02556 Beschluss vom 8. April 1993 APPELATIONSGERICHTSHOF VON PARIS VIERTE ANKLAGEKAMMER ZURUCKVERWEIS VOR DAS SCHWURGERICHT BESCHLUSS (Nr. 15, 13 Seiten) Verkündet in der Beratungskammer am 8. April neunzehnhundertdreiund neunzig Betroffene Parteien : In der Prozedur gegen: Krombach, Dieter Geboren am 5. Mai 1935 in Dresden/BRD, Sohn von Walter und Maria
STAVIGILE modafinila 200 mg Comprimidos simples USO ORAL USO ADULTO FORMA FARMACÊUTICA E APRESENTAÇÕES : Comprimidos contendo 200 mg de modafinila. Embalagem com 30 comprimidos. COMPOSIÇÃO : Cada comprimido de STAVIGILE contém: modafinila. .200 mg Excipientes q.s.p.1 comprimido (lactose, crospovidona, povidona, lactose anidra, dióxido de silício, talco, estear